Home › Funds › PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE › CDNA
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE position in CDNA
CAREDX INC · Health Care
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reported holding 500,000 shares of CDNA (CAREDX INC) in its Q1 2026 13F filing — a position valued at US$8.7M, representing 11.80% of its reported portfolio and ranking #3 among its reported holdings. PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has disclosed CDNA holdings in 5 of the last 5 reported quarters, going back to Q1 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's CDNA position evolved
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE first disclosed a stake in CDNA in Q1 2025 at 50,000 shares (US$888K). The position peaked in Q1 2026 at 500,000 shares, worth US$8.7M. Across 5 filings, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 500,000 shares valued at US$8.7M — an increase of 125,000 shares quarter over quarter.. Notable position changes include a 339% increase in Q2 2025 (shares fell 26% over the following quarter), a 94% increase in Q3 2025 (shares rose 30% over the following quarter), a 33% increase in Q1 2026 (shares rose 64% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 50.00K | $887.50K | New |
| Q2 2025 | 219.40K | $4.29M | Add |
| Q3 2025 | 425.00K | $6.18M | Add |
| Q4 2025 | 375.00K | $7.07M | Reduce |
| Q1 2026 | 500.00K | $8.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 41 other funds we track also report a position in CDNA — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M), GAGNON SECURITIES LLC (US$50.5M), Ophir Asset Management Pty Ltd (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M sh · $56.93M · Q2 2026
- GAGNON SECURITIES LLC 1.77M sh · $50.47M · Q2 2026
- Ophir Asset Management Pty Ltd 1.26M sh · $36.05M · Q2 2026
- BRAIDWELL LP 1.22M sh · $34.79M · Q2 2026
- Blue Water Life Science Advisors, LP 1.19M sh · $33.91M · Q2 2026
- Divisadero Street Capital Management, LP 700.94K sh · $19.98M · Q2 2026
- Portolan Capital Management, LLC 684.80K sh · $19.52M · Q2 2026
- Gagnon Advisors, LLC 546.89K sh · $15.59M · Q2 2026
- Palo Alto Investors LP 531.87K sh · $15.16M · Q2 2026
More on PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
FAQ
How long has PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE held CDNA?
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has disclosed CDNA holdings in 5 of the last 5 reported quarters, going back to Q1 2025.
What is PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's current position in CDNA?
As of Q1 2026, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE holds 500.00K shares of CDNA (CAREDX INC), valued at $8.68M, representing 11.80% of its reported portfolio and ranking #3.
Has PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE been buying or selling CDNA?
In the latest 13F filing (Q1 2026), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE increased its position in CDNA. The position peaked in Q1 2026 at 500.00K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include DEERFIELD MANAGEMENT COMPANY, L.P., GAGNON SECURITIES LLC, Ophir Asset Management Pty Ltd, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.